Profile for Poland Patent: 3826662
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Poland Patent: 3826662
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 12,295,987 | Dec 30, 2041 | Eli Lilly And Co | MOUNJARO | tirzepatide |
| 12,295,987 | Dec 30, 2041 | Eli Lilly And Co | MOUNJARO (AUTOINJECTOR) | tirzepatide |
| 12,295,987 | Dec 30, 2041 | Eli Lilly And Co | MOUNJARO KWIKPEN | tirzepatide |
| 12,453,758 | Jul 22, 2039 | Eli Lilly And Co | ZEPBOUND | tirzepatide |
| 12,453,758 | Jul 22, 2039 | Eli Lilly And Co | ZEPBOUND (AUTOINJECTOR) | tirzepatide |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
